Release Date: 06/07/09 10:16 Summary: Response to ASX Price and Volume Query Price Sensitive: Yes Download Document 233.26KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%